1. Home
  2. UVE vs KMDA Comparison

UVE vs KMDA Comparison

Compare UVE & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVE
  • KMDA
  • Stock Information
  • Founded
  • UVE 1990
  • KMDA 1990
  • Country
  • UVE United States
  • KMDA Israel
  • Employees
  • UVE N/A
  • KMDA N/A
  • Industry
  • UVE Property-Casualty Insurers
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UVE Finance
  • KMDA Health Care
  • Exchange
  • UVE Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • UVE 546.2M
  • KMDA 442.1M
  • IPO Year
  • UVE 1992
  • KMDA N/A
  • Fundamental
  • Price
  • UVE $19.57
  • KMDA $7.46
  • Analyst Decision
  • UVE Buy
  • KMDA Strong Buy
  • Analyst Count
  • UVE 1
  • KMDA 2
  • Target Price
  • UVE $25.00
  • KMDA $14.50
  • AVG Volume (30 Days)
  • UVE 121.7K
  • KMDA 346.0K
  • Earning Date
  • UVE 02-25-2025
  • KMDA 03-05-2025
  • Dividend Yield
  • UVE 3.93%
  • KMDA N/A
  • EPS Growth
  • UVE 4.62
  • KMDA 124.29
  • EPS
  • UVE 2.48
  • KMDA 0.27
  • Revenue
  • UVE $1,511,183,000.00
  • KMDA $158,380,000.00
  • Revenue This Year
  • UVE N/A
  • KMDA $15.37
  • Revenue Next Year
  • UVE N/A
  • KMDA $8.58
  • P/E Ratio
  • UVE $7.89
  • KMDA $28.13
  • Revenue Growth
  • UVE 12.23
  • KMDA 4.52
  • 52 Week Low
  • UVE $16.50
  • KMDA $4.74
  • 52 Week High
  • UVE $23.39
  • KMDA $9.15
  • Technical
  • Relative Strength Index (RSI)
  • UVE 41.96
  • KMDA 52.89
  • Support Level
  • UVE $19.72
  • KMDA $7.51
  • Resistance Level
  • UVE $20.61
  • KMDA $8.35
  • Average True Range (ATR)
  • UVE 0.40
  • KMDA 0.41
  • MACD
  • UVE 0.03
  • KMDA -0.02
  • Stochastic Oscillator
  • UVE 35.80
  • KMDA 33.20

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: